NYSE · Shell Companies · USD

Jena Acquisition Corporation II (JENA) Stock Analysis

Jena Acquisition Corporation II (JENA) is a Shell Companies stock listed on NYSE and quoted in US Dollar.

JENA

$10.40

−$0.09 (−0.86%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare JENA with… →

JENA Key Statistics

As of Sep 4, 2026

Trading

Open: $10.49
Previous Close: $10.49
Day's Range: 10.39–10.49
52-Week Range: 10.06–10.61
Volume: 9.30K

Valuation

Market Cap: $301.34M
P/E Ratio: unprofitable
EPS (ttm): −0.08

Financials (FY)

Revenue (FY): $0.00
Net Income (FY): −$1.84M
Profit margin: 0.00%
Shares Outstanding: 23.23M
1-Year Return: +2.56%

Dividend and dates

Avg Volume: 13.74K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

JENA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	+2.26%
2025 (partial year)	+0.69%

As of September 4, 2026.

JENA Valuation vs Shell Companies Median

Median of 587 stocks

Metric	JENA	Shell Companies median	vs median
Profit margin	0.00%	0.00%	0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values Jena Acquisition Corporation II (JENA) at $301.34M. The company sits in the Financial Services sector, in the Shell Companies industry.

The most recent close on file for JENA is $10.40, dated September 4, 2026. That is −$0.09 (−0.86%) against the previous close. The 52-week range on file runs from $10.06 to $10.61. The latest close sits 3.38% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $1.84M. Profit margin runs at 0%. Earnings per share on a trailing basis come to −0.08.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

The trailing one-year price return is +2.56%. Annualized volatility over the trailing 1 year is 3.82%.

Growth & Income

No dividend is on file for JENA.

2026 is still running; the price is +2.26% year to date.

Peer Comparison

Jena Acquisition Corporation II (JENA) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Jena Acquisition Corporation II	JENA	$301.34M	—
Churchill Capital Corp XI	CCXI	$746.38M	—
Churchill Capital Corp X	CCCX	$711.00M	—
Drugs Made In America Acquisition II Corp.	DMII	$647.83M	35.1

The Shell Companies industry average P/E ratio is 45.2x. Jena Acquisition Corporation II has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

CCCX

Churchill Capital Corp X

$711.00M

DMII

Drugs Made In America Acquisition II Corp.

$647.83M

BCSS

Bain Capital GSS Investment Corp.

$602.40M

EVAC

EQV Ventures Acquisition Corp. II

$602.01M

CXII

Churchill Capital Corp XII

$594.94M

View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Jena Acquisition Corporation II

Jena Acquisition Corporation II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Jena Acquisition Corporation II was incorporated in 2025 and is based in Las Vegas, Nevada.